Recruiting Model-informed Dose Optimization for Rivaroxaban in Children With Giant Coronary Artery Aneurysm After Kawasaki Disease NCT06978439 Conditions Aneurysm, Cardiovascular Diseases, Coronary Aneurysm, +15 more Locations Children's Hospital of Fudan University — Shanghai, Shanghai Municipality, China View Trial Details
Recruiting Excretion of Rivaroxaban in Human Breast Milk NCT06831474 Conditions Behavior, Breast Feeding, Breast Milk Collection, +12 more Locations Thomas Jefferson University Hospital — Philadelphia, Pennsylvania, United States View Trial Details
Recruiting Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 Years NCT06993636 Conditions Aneurysm, Anticoagulant Drugs, Cardiovascular Diseases, +16 more Locations Children's Hospital of Fudan University — Shanghai, Shanghai Municipality, China View Trial Details
Not Yet Recruiting Imapct of bioMarkers on Pharmacodynamics and Bleeding Risk of Direct Oral AntiCoagulants and Ticagrelor Study II NCT05764356 Conditions Apixaban, Biomarker, Bleeding, +12 more Locations Anhui Provincial Hospital#The First Affiliated Hospital Of USTC# — Hefei, Anhui, China Peking University First Hospital — Beijing, Beijing Municipality, China The Second Affiliated Hospital Of Chongqing Medical University — Chongqing, Chongqing Municipality, China The 7th People's Hospital of Zhengzhou — Zhengzhou, Henan, China View more locations Show fewer locations Loading locations... View Trial Details
Completed Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer NCT01989845 Conditions Bleeding, Cancer-associated Thrombosis, Disease Attributes, +5 more Locations Seoul National University Bundang Hospital — Seongnam, South Korea View Trial Details
